SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
BARRINGER LABORATORIES, INC.
----------------------------
(NAME OF ISSUER)
Common Stock, $0.01 Par Value
-------------------------------
(Title of Class of Securities)
-------------------------------
068508100
-------------------------------
(CUSIP Number)
Alan H. Dorsey
c/o VALUE INVESTING PARTNERS, INC.
1853 Post Road East
Westport, Connecticut 06880
Tel. No.: (203) 256-9400
-------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
- with copies to -
Bruce A. Rich, Esq.
Reid & Priest LLP
40 West 57th Street
New York, New York 10019
(212) 603-6780
December 18, 1996
---------------------------------
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject of
this Schedule 13D, and is filing this schedule because of Rule
13d-1(b)(3) or (4) check the following box [ ].
Check the following box if a fee is being paid with the
statement [].
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 (the "Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act.
(Continued on following pages)
<PAGE>
------------------------------- ---------------------
CUSIP No. 068508100 13D Page 2 of 8 Pages
------------------------------- ---------------------
------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Alan H. Dorsey
------ ----------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [ ]
------ -----------------------------------------------------------
3 SEC USE ONLY
----- -----------------------------------------------------------
4 SOURCE OF FUNDS*
PF
------ -----------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT
TO ITEM 2(d) or 2(e) [ ]
----- -----------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
---- --------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY 50,200
OWNED BY --- ----------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON WITH None
--- ----------------------------------------------
9 SOLE DISPOSITIVE POWER
50,200
---- ---------------------------------------------
10 SHARED DISPOSITIVE POWER
39,000
------ -------------- ----------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
89,200
------ -------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
------ -------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.4 %
------ -------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
------ -------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
<PAGE>
------------------------------- ---------------------
CUSIP No. 068508100 13D Page 3 of 8 Pages
------------------------------- --------------------
---- -----------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
VIP Management Corporation
---- ------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [ ]
---- --------------------------------------------------------------------
3 SEC USE ONLY
---- -------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--- ------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) [ ]
---- -------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
----- -------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY N/A
OWNED BY ---- ------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING N/A
PERSON WITH ---- -----------------------------------------------
9 SOLE DISPOSITIVE POWER
N/A
--- -----------------------------------------------
10 SHARED DISPOSITIVE POWER
39,000
---------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
39,OOO
------- -----------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
------ ----------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.4 %
------ ---------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
----- ---------------------------------------------------------------
<PAGE>
------------------------------- -------------------------------
CUSIP No. 068508100 13D Page 4 of 8 Pages
------------------------------- -------------------------------
SCHEDULE 13D
------------
ITEM 1. SECURITY AND ISSUER.
-------------------
The title of the class of equity securities to which this
statement on Schedule 13D (the "Statement") relates is the Common Stock,
$.01 par value per share ("Common Stock"), of Barringer Laboratories, Inc.,
a Delaware corporation (the "Company"). The Company's principal executive
offices are at 15000 West 6th Avenue, Suite 300, Golden, Colorado 80401-
5047.
ITEM 2. IDENTITY AND BACKGROUND.
-----------------------
(a) This Statement is being filed jointly by the following
reporting persons (hereinafter sometimes collectively referred to as the
"Filing Persons") pursuant to an Agreement of Joint Filing attached to this
Statement as Exhibit 1:
(i) Alan H. Dorsey ("Dorsey"), an individual
is an Officer of Value Investing
Partners, Inc. and the Chief Investment
Officer of VIP Management Corporation
("Management").
(ii) VIP Management, a Delaware corporation
and a wholly owned subsidiary of Value
Investing Partners, Inc., is the
investment manager of VIP Select Fund
Ltd., a British Virgin Islands
corporation (the "Fund").
(b) The address for Dorsey and Management is 1853 Post Road
East, Westport, Connecticut 06880.
(c) Dorsey's principal occupation is investment research and
management.
(d) None of the Filing Persons has been convicted during the
last five years in a criminal proceeding (excluding traffic violations or
similar misdemeanors).
(e) None of the Filing Persons has been a party during the last
five years to any civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or is subject
to a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to federal or state securities
laws or finding any violation with respect to such laws.
(f) Dorsey is a citizen of the United States.
ITEM 3. SOURCE AND AMOUNT OF FUNDS.
--------------------------
The sources of the funds used by Dorsey, and his IRA account, to
directly purchase the Company's Common Stock listed in Item 5(c) were
personal funds in the aggregate amount of $85,842.50. The source of the
funds used by the Fund to directly purchase the Company's Common Stock
listed in Item 5(c) was working capital in the aggregate amount of
$66,089.40.
ITEM 4. PURPOSE OF THE TRANSACTION.
--------------------------
The Filing Persons acquired the Company's Common Stock for
investment purposes. The Filing Persons reserve the right to purchase
additional shares, either separately or together with other persons, to
sell all or some of the shares beneficially owned by them, or to otherwise
trade in the Company's Common Stock, in open market or private
transactions, provided that in their individual or collective judgment such
transactions present an attractive (long- or short-term) opportunity for
profit.
<PAGE>
------------------------------- -------------------------------
CUSIP No. 068508100 13D Page 5 of 8 Pages
------------------------------- -------------------------------
Although the Filing Persons have no plans or proposals which
relate to or would result in any transactions specified in paragraphs (a)
through (j) of this Item, the Filing Persons may separately or collectively
consider plans or proposals relating to or resulting in one or more such
transaction in the future depending upon factors then existing, such as the
market for the Company's Common Stock, the Company's then prospects,
alternative investment opportunities, general economic and money-market
investment conditions, as well as other factors deemed relevant from time
to time.
ITEM 5. INTEREST IN THE SECURITIES OF THE ISSUER.
----------------------------------------
(a) The beneficial ownership of each of the Filing Persons of the
Company's Common Stock as of the date hereof is as follows:
(i) Dorsey beneficially owns 200 shares of the Company's
Common Stock for his own account and 50,000 for his IRA account,
representing 3% of the outstanding number of shares of Common Stock (based
upon 1,652,016 shares outstanding as of September 30, 1996, as reported in
the Company's Form 10-QSB for the fiscal quarter ended September 30, 1996).
In addition, as Chief Investment Officer of Management, Dorsey may be
deemed the indirect beneficial owner of 39,000 shares beneficially owned by
the Fund, thus his aggregate shares total 89,200, representing 5.4% of the
outstanding Company's Common Stock.
(ii) Management indirectly beneficially owns 39,000
shares of the Company's Common Stock, representing 2.4% of the outstanding
number of shares of Common Stock.
(b) Dorsey has the sole power to vote or dispose of 50,200
shares and the shared power to dispose of 39,000 shares. Management has no
voting power, but does have the power to dispose of 39,000 shares.
(c) The Filing Persons effected the following transactions in
the Company's Common Stock in the over-the-counter market during the past
sixty (60) days:
=====================================================================
FILING PERSON TRADE DATE NUMBER OF SHARES SHARE PRICE
(includes
commissions)
---------------------------------------------------------------------
Alan H. 11/29/96 100* $2.33
Dorsey
Alan H. 12/13/96 100* $1.95
Dorsey
Alan H. 11/04/96 40,000* $1.69
Dorsey IRA
Alan H. 11/18/96 10,000* $1.79
Dorsey IRA
VIP Select 11/04/96 40,000* $1.70
Fund
VIP Select 11/18/96 10,000** $1.77
Fund
VIP Select 12/17/96 1,000* $1.69
Fund
VIP Select 12/18/96 8,000* $1.78
Fund
=========================================================================
* Purchase ** Sale
(d) Not applicable.
(e) Not applicable.
<PAGE>
------------------------------- -------------------------------
CUSIP No. 068508100 13D Page 6 of 8 Pages
------------------------------- -------------------------------
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
------- -------------------------------------------------------------
RESPECT TO SECURITIES OF THE ISSUER.
-----------------------------------
None.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
------- --------------------------------
Exhibit 1 - Agreement of Joint Filing
<PAGE>
SIGNATURES
----------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: December 24, 1996
/s/ Alan H. Dorsey
---------------------------------
ALAN H. DORSEY
VIP MANAGEMENT CORPORATION
By:/s/ Alan H. Dorsey
-------------------------
Alan H. Dorsey
Vice President
<PAGE>
AGREEMENT OF JOINT FILING
-------------------------
In accordance with Rule 13D-1(f) under the Securities Exchange
Act of 1934, as amended, the undersigned hereby agree to the joint filing
of a statement on Schedule 13D or any amendments thereto, with respect to
the Common Stock, $.01 par value, of Barringer Laboratories, Inc. and that
this Agreement be included as an Exhibit in such filing.
This Agreement may be executed in any number of counterparts each
of which shall be deemed to be an original and all of which together shall
be deemed to constitute one and the same Agreement.
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement
on this 24th day of December, 1996.
VIP MANAGEMENT CORPORATION
By:/s/ Alan H. Dorsey
------------------------------------
Alan H. Dorsey
Vice President
/s/ Alan H. Dorsey
----------------------------------------
ALAN H. DORSEY
